查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1757449

血清分離凝膠市場：全球產業分析、市場規模、佔有率、成長、趨勢與未來預測（2025-2032）

Serum Separation Gel Market: Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2025 - 2032
出版日期: | 出版商: Persistence Market Research | 英文 197 Pages | 商品交期: 2-5個工作天內

價格
簡介目錄

Persistence Market Research 最近發布了一份關於全球血清分離凝膠市場的綜合報告，詳細分析了關鍵市場動態，包括促進因素、新興趨勢、機會和挑戰。該報告深入分析了市場格局，幫助相關人員做出明智的決策。

關鍵見解

  • 血清分離凝膠市場規模（2025年）：78.8億美元
  • 市場規模預測（以金額為準，2032年）：125.6億美元
  • 全球市場成長率（2025-2032年複合年成長率）：6%

血清分離凝膠市場：分析範圍

血清分離凝膠市場涵蓋用於在離心過程中分離血清和血細胞的採血管材料。這些凝膠因其高效、無污染的血液分析而被廣泛應用於診斷實驗室、醫院和研究機構。慢性病和感染疾病的日益流行，以及對高效可靠診斷程序的重視，推動了血清分離凝膠的需求。此外，凝膠配方和試管設計的技術進步也促進了樣品穩定性和操作性的提高，也推動了血清分離凝膠市場的發展。

市場成長動力：

全球血清分離凝膠市場的成長動力源於對先進診斷技術日益成長的需求，而這些需求源於心血管疾病、糖尿病和癌症等慢性疾病負擔的日益加重。老年人口的不斷成長，使得老年人更容易出現需要頻繁進行診斷檢查的疾病，這進一步擴大了市場需求。此外，新興經濟體醫療基礎設施的不斷改善、診斷實驗室和血庫數量的不斷增加，也推動了血清分離凝膠的普及率不斷上升。凝膠配方的改進，使其能夠提高分離效率並延長樣品穩定性，也推動了市場的成長。

市場限制：

儘管成長前景看好，血清分離凝膠市場仍面臨一些挑戰。先進凝膠配方的高昂製造成本可能會阻礙其市場滲透，尤其是在價格敏感的地區。此外，凝膠干擾某些分析測試的風險可能會影響測試準確性，並限制某些凝膠類型的應用。監管合規性和品管問題，尤其是在新興市場，也可能對產品在全球市場的持續供應和接受度構成障礙。

市場機會：

由於技術創新和向未開發地區的擴張，血清分離凝膠市場提供了巨大的成長機會。奈米技術和生物相容性材料的發展為開發性能和安全性更高的下一代凝膠提供了潛力。亞太、南美和拉丁美洲的新興經濟體由於醫療支出的增加和診斷基礎設施的改善，為市場擴張提供了肥沃的土壤。凝膠製造商和診斷設備供應商之間的合作以及研發投入進一步推動了技術創新，使市場參與者能夠更有效地滿足不斷變化的醫療需求。

本報告回答的關鍵問題

  • 推動全球血清分離凝膠市場成長的關鍵因素有哪些？
  • 血清分離膠最需要的地區和應用領域有哪些？
  • 診斷技術的進步如何影響市場動態？
  • 血清分離凝膠市場的主要企業有哪些？他們採用什麼策略來保持競爭力？
  • 全球血清分離凝膠市場的新興趨勢和未來預測是什麼？

目錄

第1章執行摘要

第2章 市場概述

  • 市場範圍和定義
  • 市場動態
    • 驅動程式
    • 限制因素
    • 機會
    • 任務
    • 主要趨勢
  • 宏觀經濟因素
    • 全球產業展望
    • 全球GDP成長前景
  • COVID-19影響分析
  • 預測因子：相關性和影響力

第3章 加值分析

  • 監管狀況
  • 管道分析
  • 依產品類型分析採用狀況
  • 價值鏈分析
  • 廠商主要促銷策略
  • PESTLE分析
  • 波特五力分析

第4章 全球血清分離凝膠市場展望

  • 主要亮點
    • 市場規模及與前一年同期比較率（以金額為準）
    • 絕對的商機
  • 市場規模分析與預測（以金額為準）
    • 歷史市場規模分析（以金額為準，2019-2024）
    • 市場規模分析與預測（以金額為準，2025-2032）
  • 全球血清分離凝膠市場按產品類型分類的前景
    • 簡介/主要發現
    • 按產品類型分類的歷史市場規模分析（以金額為準，2019-2024 年）
    • 按產品類型分類的市場規模分析與預測（以金額為準，2025-2032 年）
      • 帶有整合管的血清分離凝膠
      • 一體化無管血清分離膠
    • 市場吸引力分析：按產品類型
  • 全球血清分離凝膠市場依最終用途展望
    • 簡介/主要發現
    • 按最終用途分類的歷史市場規模分析（以金額為準，2019-2024 年）
    • 按最終用途分類的市場規模分析和預測（以金額為準，2025-2032 年）
      • 醫院和診所
      • 診斷實驗室
      • 血庫
      • 製藥和生物技術公司
      • 其他
    • 市場吸引力分析：按最終用途

第5章 全球血清分離凝膠市場區域展望

  • 主要亮點
  • 按地區分類的歷史市場規模分析（以金額為準，2019-2024 年）
  • 各地區市場規模分析及預測（以金額為準，2025-2032）
    • 北美洲
    • 歐洲
    • 亞太地區
    • 南亞和大洋洲
    • 拉丁美洲
    • 中東和非洲
  • 市場吸引力分析：區域

第6章北美血清分離凝膠市場展望：

第7章歐洲血清分離凝膠市場展望：

第8章東亞精華分離凝膠市場展望：

第9章南亞和大洋洲精華分離凝膠市場展望：

第 10 章拉丁美洲血清分離凝膠市場展望：

第11章中東與非洲血清分離凝膠市場展望：

第12章競爭格局

  • 市場佔有率分析（2025年）
  • 市場結構
    • 競爭強度圖：按市場
    • 競爭儀錶板
  • 公司簡介（詳情：概述、財務狀況、策略、最新發展）
    • Merck KGaA
    • Qiagen NV
    • Cardinal Health Inc.
    • Medtronic PLC
    • Bio-Rad Laboratories
    • Microfluidics International Corporation
    • BioVision, Inc.
    • Danaher Corporation
    • Becton Dickinson &Company
    • F. Hoffmann-La Roche Ltd.

第13章 附錄

  • 分析方法
  • 分析前提條件
  • 首字母縮寫和簡稱
簡介目錄
Product Code: PMRREP35425

Persistence Market Research has recently released a comprehensive report on the global Serum Separation Gel Market, providing an in-depth analysis of key market dynamics, including driving forces, emerging trends, opportunities, and challenges. This report offers a detailed understanding of the market landscape, helping stakeholders make well-informed decisions.

Key Insights:

  • Serum Separation Gel Market Size (2025E): US$ 7.88 Bn
  • Projected Market Value (2032F): US$ 12.56 Bn
  • Global Market Growth Rate (CAGR 2025 to 2032): 6%

Serum Separation Gel Market - Report Scope:

The serum separation gel market encompasses materials used in blood collection tubes to separate serum from blood cells during centrifugation. These gels are widely employed in diagnostic labs, hospitals, and research settings, owing to their efficiency in facilitating accurate and contamination-free blood analysis. The increasing prevalence of chronic and infectious diseases, along with a growing emphasis on efficient and reliable diagnostic procedures, is fueling the demand for serum separation gels. The market is also benefiting from technological advancements in gel formulations and tube designs that enhance sample stability and handling.

Market Growth Drivers:

The growth of the global serum separation gel market is driven by the rising demand for advanced diagnostic techniques due to the increasing burden of chronic diseases such as cardiovascular disorders, diabetes, and cancer. The growth in geriatric population, which is more susceptible to health conditions requiring frequent diagnostic testing, is further augmenting market demand. Additionally, the expansion of healthcare infrastructure across emerging economies and the increasing number of diagnostic laboratories and blood banks are contributing to higher adoption rates of serum separation gels. Improvements in gel composition that allow for better separation efficiency and longer sample stability are also encouraging market growth.

Market Restraints:

Despite a favorable growth outlook, the serum separation gel market faces certain challenges. High manufacturing costs associated with advanced gel formulations can hinder market penetration, especially in price-sensitive regions. Moreover, the risk of gel interference with certain analytical tests may affect test accuracy and limit the application of some gel types. Regulatory compliance and quality control issues, particularly in developing nations, may also pose barriers to consistent product availability and acceptance in global markets.

Market Opportunities:

The serum separation gel market presents numerous growth opportunities fueled by innovation and expansion into untapped regions. Advances in nanotechnology and bio-compatible materials offer potential for the development of next-generation gels with enhanced performance and safety profiles. Emerging economies in Asia Pacific, South Asia, and Latin America offer fertile ground for market expansion due to growing healthcare expenditure and improvements in diagnostic infrastructure. Collaborations between gel manufacturers and diagnostic equipment providers, along with investments in R&D, can further boost innovation and enable market players to address evolving healthcare demands more effectively.

Key Questions Answered in the Report:

  • What are the primary factors driving the global serum separation gel market's growth?
  • Which regions and application segments are experiencing the highest demand for serum separation gels?
  • How are advancements in diagnostic technologies influencing market dynamics?
  • Who are the key players in the serum separation gel market, and what strategies are they adopting to stay competitive?
  • What are the emerging trends and future projections for the global serum separation gel market?

Competitive Intelligence and Business Strategy:

Leading companies in the global serum separation gel market, such as Qiagen N.V., Cardinal Health Inc., Medtronic PLC, Bio-Rad Laboratories, and Becton Dickinson & Company, are focusing on expanding their product portfolios and enhancing the performance of their gel-based separation products. These players are investing in research and development to create gels with faster separation time, improved stability, and compatibility with automated testing systems. Strategic partnerships with diagnostic labs and healthcare institutions, along with an emphasis on global distribution networks, are key tactics being employed to strengthen market presence.

Companies Covered in This Report:

  • Qiagen N.V.
  • Cardinal Health Inc.
  • Medtronic PLC
  • Bio-Rad Laboratories
  • Microfluidics International Corporation
  • BioVision, Inc.
  • Danaher Corporation
  • Becton Dickinson & Company
  • F. Hoffmann-La Roche Ltd.
  • Merck KGaA

Market Segmentation

By Product Type

  • Serum Separation Gel With Integrated Tubes
  • Serum Separation Gel Without Integrated Tubes

By End-use

  • Hospitals & Clinics
  • Diagnostic Laboratories
  • Blood Banks
  • Pharmaceutical & Biotechnology Companies
  • Others

By Region

  • North America
  • Europe
  • Asia Pacific
  • South Asia and Oceania
  • Latin America
  • Middle East and Africa

Table of Contents

1. Executive Summary

  • 1.1. Global Serum Separation Gel Market Snapshot, 2025 and 2032
  • 1.2. Market Opportunity Assessment, 2025-2032, US$ Bn
  • 1.3. Key Market Trends
  • 1.4. Future Market Projections
  • 1.5. Premium Market Insights
  • 1.6. Industry Developments and Key Market Events
  • 1.7. PMR Analysis and Recommendations

2. Market Overview

  • 2.1. Market Scope and Definition
  • 2.2. Market Dynamics
    • 2.2.1. Drivers
    • 2.2.2. Restraints
    • 2.2.3. Opportunity
    • 2.2.4. Challenges
    • 2.2.5. Key Trends
  • 2.3. Macro-Economic Factors
    • 2.3.1. Global Sectorial Outlook
    • 2.3.2. Global GDP Growth Outlook
  • 2.4. COVID-19 Impact Analysis
  • 2.5. Forecast Factors - Relevance and Impact

3. Value Added Insights

  • 3.1. Regulatory Landscape
  • 3.2. Pipeline Analysis
  • 3.3. Product Type Adoption Analysis
  • 3.4. Value Chain Analysis
  • 3.5. Key Promotional Strategies by Manufacturers
  • 3.6. PESTLE Analysis
  • 3.7. Porter's Five Force Analysis

4. Global Serum Separation Gel Market Outlook:

  • 4.1. Key Highlights
    • 4.1.1. Market Size (US$ Bn) and Y-o-Y Growth
    • 4.1.2. Absolute $ Opportunity
  • 4.2. Market Size (US$ Bn) Analysis and Forecast
    • 4.2.1. Historical Market Size (US$ Bn) Analysis, 2019-2024
    • 4.2.2. Market Size (US$ Bn) Analysis and Forecast, 2025-2032
  • 4.3. Global Serum Separation Gel Market Outlook: Product Type
    • 4.3.1. Introduction / Key Findings
    • 4.3.2. Historical Market Size (US$ Bn) Analysis, By Product Type, 2019-2024
    • 4.3.3. Market Size (US$ Bn) Analysis and Forecast, By Product Type, 2025-2032
      • 4.3.3.1. Serum Separation Gel With Integrated Tubes
      • 4.3.3.2. Serum Separation Gel Without Integrated Tubes
    • 4.3.4. Market Attractiveness Analysis: Product Type
  • 4.4. Global Serum Separation Gel Market Outlook: End-use
    • 4.4.1. Introduction/Key Findings
    • 4.4.2. Historical Market Size (US$ Bn) Analysis, By End-use, 2019-2024
    • 4.4.3. Market Size (US$ Bn) Analysis and Forecast, By End-use, 2025-2032
      • 4.4.3.1. Hospitals & Clinics
      • 4.4.3.2. Diagnostic Laboratories
      • 4.4.3.3. Blood Banks
      • 4.4.3.4. Pharmaceutical & Biotechnology Companies
      • 4.4.3.5. Others
    • 4.4.4. Market Attractiveness Analysis: End-use

5. Global Serum Separation Gel Market Outlook: Region

  • 5.1. Key Highlights
  • 5.2. Historical Market Size (US$ Bn) Analysis, By Region, 2019-2024
  • 5.3. Market Size (US$ Bn) Analysis and Forecast, By Region, 2025-2032
    • 5.3.1. North America
    • 5.3.2. Europe
    • 5.3.3. Asia Pacific
    • 5.3.4. South Asia and Oceania
    • 5.3.5. Latin America
    • 5.3.6. Middle East & Africa
  • 5.4. Market Attractiveness Analysis: Region

6. North America Serum Separation Gel Market Outlook:

  • 6.1. Key Highlights
  • 6.2. Historical Market Size (US$ Bn) Analysis, By Market, 2019-2024
    • 6.2.1. By Country
    • 6.2.2. By Product Type
    • 6.2.3. By End-use
  • 6.3. Market Size (US$ Bn) Analysis and Forecast, By Country, 2025-2032
    • 6.3.1. U.S.
    • 6.3.2. Canada
  • 6.4. Market Size (US$ Bn) Analysis and Forecast, By Product Type, 2025-2032
    • 6.4.1. Serum Separation Gel With Integrated Tubes
    • 6.4.2. Serum Separation Gel Without Integrated Tubes
  • 6.5. Market Size (US$ Bn) Analysis and Forecast, By End-use, 2025-2032
    • 6.5.1. Hospitals & Clinics
    • 6.5.2. Diagnostic Laboratories
    • 6.5.3. Blood Banks
    • 6.5.4. Pharmaceutical & Biotechnology Companies
    • 6.5.5. Others
  • 6.6. Market Attractiveness Analysis

7. Europe Serum Separation Gel Market Outlook:

  • 7.1. Key Highlights
  • 7.2. Historical Market Size (US$ Bn) Analysis, By Market, 2019-2024
    • 7.2.1. By Product Type
    • 7.2.2. By End-use
  • 7.3. Market Size (US$ Bn) Analysis and Forecast, By Country, 2025-2032
    • 7.3.1. Germany
    • 7.3.2. France
    • 7.3.3. U.K.
    • 7.3.4. Italy
    • 7.3.5. Spain
    • 7.3.6. Russia
    • 7.3.7. Turkey
    • 7.3.8. Rest of Europe
  • 7.4. Market Size (US$ Bn) Analysis and Forecast, By Product Type, 2025-2032
    • 7.4.1. Serum Separation Gel With Integrated Tubes
    • 7.4.2. Serum Separation Gel Without Integrated Tubes
  • 7.5. Market Size (US$ Bn) Analysis and Forecast, By End-use, 2025-2032
    • 7.5.1. Hospitals & Clinics
    • 7.5.2. Diagnostic Laboratories
    • 7.5.3. Blood Banks
    • 7.5.4. Pharmaceutical & Biotechnology Companies
    • 7.5.5. Others
  • 7.6. Market Attractiveness Analysis

8. East Asia Serum Separation Gel Market Outlook:

  • 8.1. Key Highlights
  • 8.2. Historical Market Size (US$ Bn) Analysis, By Market, 2019-2024
    • 8.2.1. By Country
    • 8.2.2. By Product Type
    • 8.2.3. By End-use
  • 8.3. Market Size (US$ Bn) Analysis and Forecast, By Country, 2025-2032
    • 8.3.1. China
    • 8.3.2. Japan
    • 8.3.3. South Korea
  • 8.4. Market Size (US$ Bn) Analysis and Forecast, By Product Type, 2025-2032
    • 8.4.1. Serum Separation Gel With Integrated Tubes
    • 8.4.2. Serum Separation Gel Without Integrated Tubes
  • 8.5. Market Size (US$ Bn) Analysis and Forecast, By End-use, 2025-2032
    • 8.5.1. Hospitals & Clinics
    • 8.5.2. Diagnostic Laboratories
    • 8.5.3. Blood Banks
    • 8.5.4. Pharmaceutical & Biotechnology Companies
    • 8.5.5. Others
  • 8.6. Market Attractiveness Analysis

9. South Asia & Oceania Serum Separation Gel Market Outlook:

  • 9.1. Key Highlights
  • 9.2. Historical Market Size (US$ Bn) Analysis, By Market, 2019-2024
    • 9.2.1. By Country
    • 9.2.2. By Product Type
    • 9.2.3. By End-use
  • 9.3. Market Size (US$ Bn) Analysis and Forecast, By Country, 2025-2032
    • 9.3.1. India
    • 9.3.2. Southeast Asia
    • 9.3.3. ANZ
    • 9.3.4. Rest of South Asia & Oceania
  • 9.4. Market Size (US$ Bn) Analysis and Forecast, By Product Type, 2025-2032
    • 9.4.1. Serum Separation Gel With Integrated Tubes
    • 9.4.2. Serum Separation Gel Without Integrated Tubes
  • 9.5. Market Size (US$ Bn) Analysis and Forecast, By End-use, 2025-2032
    • 9.5.1. Hospitals & Clinics
    • 9.5.2. Diagnostic Laboratories
    • 9.5.3. Blood Banks
    • 9.5.4. Pharmaceutical & Biotechnology Companies
    • 9.5.5. Others
  • 9.6. Market Attractiveness Analysis

10. Latin America Serum Separation Gel Market Outlook:

  • 10.1. Key Highlights
  • 10.2. Historical Market Size (US$ Bn) Analysis, By Market, 2019-2024
    • 10.2.1. By Country
    • 10.2.2. By Product Type
    • 10.2.3. By End-use
  • 10.3. Market Size (US$ Bn) Analysis and Forecast, By Country, 2025-2032
    • 10.3.1. Brazil
    • 10.3.2. Mexico
    • 10.3.3. Rest of Latin America
  • 10.4. Market Size (US$ Bn) Analysis and Forecast, By Product Type, 2025-2032
    • 10.4.1. Serum Separation Gel With Integrated Tubes
    • 10.4.2. Serum Separation Gel Without Integrated Tubes
  • 10.5. Market Size (US$ Bn) Analysis and Forecast, By End-use, 2025-2032
    • 10.5.1. Hospitals & Clinics
    • 10.5.2. Diagnostic Laboratories
    • 10.5.3. Blood Banks
    • 10.5.4. Pharmaceutical & Biotechnology Companies
    • 10.5.5. Others
  • 10.6. Market Attractiveness Analysis

11. Middle East & Africa Serum Separation Gel Market Outlook:

  • 11.1. Key Highlights
  • 11.2. Historical Market Size (US$ Bn) Analysis, By Market, 2019-2024
    • 11.2.1. By Country
    • 11.2.2. By Product Type
    • 11.2.3. By End-use
  • 11.3. Market Size (US$ Bn) Analysis and Forecast, By Country, 2025-2032
    • 11.3.1. GCC Countries
    • 11.3.2. Egypt
    • 11.3.3. South Africa
    • 11.3.4. Northern Africa
    • 11.3.5. Rest of Middle East & Africa
  • 11.4. Market Size (US$ Bn) Analysis and Forecast, By Product Type, 2025-2032
    • 11.4.1. Serum Separation Gel With Integrated Tubes
    • 11.4.2. Serum Separation Gel Without Integrated Tubes
  • 11.5. Market Size (US$ Bn) Analysis and Forecast, By End-use, 2025-2032
    • 11.5.1. Hospitals & Clinics
    • 11.5.2. Diagnostic Laboratories
    • 11.5.3. Blood Banks
    • 11.5.4. Pharmaceutical & Biotechnology Companies
    • 11.5.5. Others
  • 11.6. Market Attractiveness Analysis

12. Competition Landscape

  • 12.1. Market Share Analysis, 2025
  • 12.2. Market Structure
    • 12.2.1. Competition Intensity Mapping By Market
    • 12.2.2. Competition Dashboard
  • 12.3. Company Profiles (Details - Overview, Financials, Strategy, Recent Developments)
    • 12.3.1. Merck KGaA
      • 12.3.1.1. Overview
      • 12.3.1.2. Segments and Product Types
      • 12.3.1.3. Key Financials
      • 12.3.1.4. Market Developments
      • 12.3.1.5. Market Strategy
    • 12.3.2. Qiagen N.V.
    • 12.3.3. Cardinal Health Inc.
    • 12.3.4. Medtronic PLC
    • 12.3.5. Bio-Rad Laboratories
    • 12.3.6. Microfluidics International Corporation
    • 12.3.7. BioVision, Inc.
    • 12.3.8. Danaher Corporation
    • 12.3.9. Becton Dickinson & Company
    • 12.3.10. F. Hoffmann-La Roche Ltd.

13. Appendix

  • 13.1. Research Methodology
  • 13.2. Research Assumptions
  • 13.3. Acronyms and Abbreviations